Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Biotechnology
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (OTCID:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(1502)
•••
Duster340
X
Comment by
Duster340
on Apr 12, 2024 10:13am
RE:I remember
acctually i did very well on this stock, you just have to know when to get in and when to get out, there have been several run ups and declines in the last 4 months alone. but anyone still holding
...more
(0)
•••
Zartoshis
X
Post by
Zartoshis
on Apr 12, 2024 12:55am
I remember
I was here 2 years ago when this stock first crashed down to $1.5. Still remember bugsy, mugs, duster and a couple others. i know you guys lost a lot of money on this stock, but worst of
...more
From cloud to computing everywhere: the next phase of AI
posted May 10, 2026 9:00am by
Stockhouse Publishing Ltd.
-
|
AI is no longer confined to massive data centers. A new Financial Times report reveals how “compute everywhere” is reshaping the future of AI — bringing faster, smarter, and more efficient intelligence directly to devices, infrastructure, and industry worldwide. ...See the Shift
(17)
•••
mstrmnds
X
Post by
mstrmnds
on Apr 11, 2024 3:54pm
Acquisition
Antibe is likely to be acquired for 10-20x vWAP after FDA disclosure GLTA
(0)
•••
Gessurong
X
Comment by
Gessurong
on Apr 11, 2024 10:31am
RE:Update
tthey tell you what you want to hear in the moment.
(1502)
•••
Duster340
X
Post by
Duster340
on Apr 10, 2024 12:04pm
Dan needs to
be a man and own up to his agreement. lol Dan Legault, Antibe’s CEO. “Nonetheless, we acknowledge the fact that we agreed to binding arbitration in a foreign jurisdiction. Antibe respects the
...more
(15)
•••
SimonSaysLues
X
Post by
SimonSaysLues
on Apr 10, 2024 10:07am
On the CEO.ca board
People are complaining about the rules in the singapore court as if it's some backwards rural court. The fail to realize that their commerce, technology and wealth is the 5th in the
...more
(0)
•••
Gessurong
X
Comment by
Gessurong
on Apr 10, 2024 9:56am
RE:draw no conclusions
(1502)
•••
Duster340
X
Post by
Duster340
on Apr 10, 2024 9:18am
They bought🃏🀄
themselves eight more days. they are just playing out there cards, maybe drag out another payday or two. stick a fork in antibe they are done.
(3)
•••
Chianchin
X
Comment by
Chianchin
on Apr 10, 2024 8:15am
RE:Lol mushy Nov 3 2021
My offer still stands to help Mr Mugsy, with some $$ for food provided that he/she admits in wrting of her/his total investemt incompetance. Come on Mr Mugsy you can do it ten years later.
(15)
•••
SimonSaysLues
X
Post by
SimonSaysLues
on Apr 09, 2024 11:49pm
Lol mushy Nov 3 2021
If you are looking for potential items that could move the stock ... here are a few things to think about ... 1. 346 (acute) fast-track application and then a further acceptance from FDA 60 days later
...more
(3)
•••
Chianchin
X
Comment by
Chianchin
on Apr 09, 2024 11:46pm
RE:RE:Expected PR = Good News
MrMugsy, delutional as usual and lost all is cash. Anyone agrees with Mugsy? oh..I forgot mugsy has secret aliases>
(0)
•••
Gessurong
X
Comment by
Gessurong
on Apr 09, 2024 11:15pm
RE:RE:Expected PR = Good News
You never mentioned bankruptcy and delisting. Why would you buy shares last week if bankruptcy was expected?
(15)
•••
SimonSaysLues
X
Comment by
SimonSaysLues
on Apr 09, 2024 10:44pm
RE:RE:Expected PR = Good News
Unexpected lol. At 2 cents your big mouth will still be flapping. Scamming Bafoons are still unchecked. Welcome to Canadian small cap! Good for you mushy. Give the
...more
(128)
•••
MrMugsy
X
Comment by
MrMugsy
on Apr 09, 2024 10:10pm
RE:Expected PR = Good News
Now some very important cards to play. The only unexpected part of this game is the FDA hold. To do blood testing or not? That is likely the question. Can we get to resolution quickly
...more
(128)
•••
MrMugsy
X
Post by
MrMugsy
on Apr 09, 2024 10:06pm
hahaha !
Best game ever !!!! Hold on tight as we loop-d-loop !!!!
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
AI Beyond the Data Center: The Rise of Computing Everywhere
Podcasts